Go offline with the Player FM app!
A Daily Pill for Dog Lymphoma? The Promise of Monepantel Explained | Kim Agnew, BVSc #287
Manage episode 493121727 series 1226127
Originally aired in 2023, Molly Jacobson interviews Dr. Kim Agnew about the groundbreaking trials of Monepantel, a sheep dewormer repurposed as a potential treatment for canine lymphoma. Discover the science behind this innovative therapy, its potential to stabilize lymphoma, and how it compares to traditional treatments like chemotherapy and prednisone.
Key Topics:
- What is Monepantel, and how was it discovered?
- The mechanism behind Monepantel's ability to target cancer cells.
- Early trial results: Quality of life and stability for dogs with B-cell lymphoma.
- How Monepantel compares to prednisone and chemotherapy.
- Insights into ongoing and future clinical trials.
- How dog lovers can participate in studies.
Your Voice Matters!
If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question.
Related Videos:
https://www.youtube.com/watch?v=_92w6TTXM5c
https://www.youtube.com/watch?v=uAZrPM1X8ww
Related Links:
PharmAust Dog Lymphoma Clinical Trial: https://www.pharmaust.com/petdogtrial/
Chapters:
00:00 Introduction
00:30 Meet Dr. Kim Agnew and Monepantel Overview
01:15 The Origin of Monepantel: From Dewormer to Cancer Fighter
03:30 How Monepantel Targets Cancer Cells
07:00 Insights on Clinical Trials for Canine Lymphoma
09:30 Benefits of Monepantel: A Daily Pill for Dogs
12:00 Comparing Monepantel to Chemotherapy and Prednisone
14:45 Early Trial Results: Stabilizing Lymphoma in Dogs
18:30 Why Lymphoma Was Chosen for Trials
20:00 Potential for Treating Other Cancers in Dogs
23:15 How to Enroll Dogs in Clinical Trials
26:45 Side Effects and Safety of Monepantel
31:00 Future Trials and Research Goals
34:30 Closing Thoughts and Resources
33:55 Closing Remarks and Resources
Get to know Kim Agnew, BVSc:
https://www.dogcancer.com/people/kim-agnew-bvsc/
For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/
Learn more about your ad choices. Visit megaphone.fm/adchoices
290 episodes
Manage episode 493121727 series 1226127
Originally aired in 2023, Molly Jacobson interviews Dr. Kim Agnew about the groundbreaking trials of Monepantel, a sheep dewormer repurposed as a potential treatment for canine lymphoma. Discover the science behind this innovative therapy, its potential to stabilize lymphoma, and how it compares to traditional treatments like chemotherapy and prednisone.
Key Topics:
- What is Monepantel, and how was it discovered?
- The mechanism behind Monepantel's ability to target cancer cells.
- Early trial results: Quality of life and stability for dogs with B-cell lymphoma.
- How Monepantel compares to prednisone and chemotherapy.
- Insights into ongoing and future clinical trials.
- How dog lovers can participate in studies.
Your Voice Matters!
If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question.
Related Videos:
https://www.youtube.com/watch?v=_92w6TTXM5c
https://www.youtube.com/watch?v=uAZrPM1X8ww
Related Links:
PharmAust Dog Lymphoma Clinical Trial: https://www.pharmaust.com/petdogtrial/
Chapters:
00:00 Introduction
00:30 Meet Dr. Kim Agnew and Monepantel Overview
01:15 The Origin of Monepantel: From Dewormer to Cancer Fighter
03:30 How Monepantel Targets Cancer Cells
07:00 Insights on Clinical Trials for Canine Lymphoma
09:30 Benefits of Monepantel: A Daily Pill for Dogs
12:00 Comparing Monepantel to Chemotherapy and Prednisone
14:45 Early Trial Results: Stabilizing Lymphoma in Dogs
18:30 Why Lymphoma Was Chosen for Trials
20:00 Potential for Treating Other Cancers in Dogs
23:15 How to Enroll Dogs in Clinical Trials
26:45 Side Effects and Safety of Monepantel
31:00 Future Trials and Research Goals
34:30 Closing Thoughts and Resources
33:55 Closing Remarks and Resources
Get to know Kim Agnew, BVSc:
https://www.dogcancer.com/people/kim-agnew-bvsc/
For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/
Learn more about your ad choices. Visit megaphone.fm/adchoices
290 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.